FDA approves Asparlas for acute lymphoblastic leukemia


The FDA today approved calaspargase pegol-mknl as part of a multiagent chemotherapeutic regimen for pediatric and young adult patients with acute lymphoblastic leukemia. Calaspargase pegol-mknl (Aspar…

Read more